Skip to main content
Equibles

Squarepoint Ops LLC

Position in MLTX — MoonLake Immunotherapeutics

CIK 1642575 NEW YORK, NY
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,657,812
-$396,632 QoQ
Shares Held
85,147
-22.7% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#74
of 172 holders
Holding Since
Jun 2023
12 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Derivatives in MLTX

reported options exposure · as of Sep 30, 2025
CallValue
$92,493
CallShares
12,900
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,238,596,915 across 255 Biotechnology names. MLTX ranks #84 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 198,567 $123,814,467
2 BBIO
BridgeBio Pharma, Inc.
 1,191,732 $88,760,199
3 ALNY
Alnylam Pharmaceuticals, Inc.
 233,999 $70,440,718
4 INSM
INSMED Inc
 616,464 $65,727,391
5 ARGX
Argenx SE
 58,400 $54,181,768
6 RYTM
Rhythm Pharmaceuticals, Inc.
 422,921 $46,956,918
7 APGE
Apogee Therapeutics, Inc.
 290,713 $38,586,336
8 AXSM
Axsome Therapeutics, Inc.
 154,605 $37,842,665

All Filings in MLTX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,657,812 85,147
2026-03-31 $2,054,444 110,217
2025-12-31 $1,603,215 121,640
2025-09-30 $220,047 30,690
2025-09-30 $92,493 12,900
2025-06-30 $829,351 17,571
2025-03-31 $661,923 16,942
2024-12-31 $703,950 13,000
2024-09-30 $322,788 6,402
2024-06-30 $322,739 7,340
2024-06-30 $549,625 12,500
2024-06-30 $549,625 12,500
2023-12-31 $1,141,552 18,903
2023-09-30 $792,813 13,909
2023-06-30 $2,112,981 41,431